Jane Street Group, LLC Cerevel Therapeutics Holdings, Inc. Transaction History
Jane Street Group, LLC
- $88.2 Billion
- Q2 2024
A detailed history of Jane Street Group, LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 269,948 shares of CERE stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
269,948Holding current value
$0% of portfolio
0.01%Shares
11 transactions
Others Institutions Holding CERE
# of Institutions
21Shares Held
5.93MCall Options Held
27.3KPut Options Held
0-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Segantii Capital Management LTD1.14MShares$05.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA393KShares$00.95% of portfolio
-
Tekla Capital Management LLC176KShares$00.22% of portfolio
-
Credit Suisse Ag Zurich, V8112KShares$00.0% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...